Intra-Cellular Therapies Inc (ITCI) stock saw a decline, ending the day at $126.9 which represents a decrease of $-0.29 or -0.23% from the prior close of $127.19. The stock opened at $127.24 and ...

JPMorgan has updated its outlook on Primo Brands Corp. (NYSE: PRMB), raising the price target to $38.00 from the previous $33.00, while maintaining an Overweight rating on the company's shares.

KeyBanc Capital Markets adjusted its outlook on Spotify Technology SA (NYSE:SPOT), increasing the price target to $675 from the previous $600, while maintaining an Overweight rating on the company's ...

Whether you’ve just started trying to conceive or have undergone multiple rounds of IVF, there are many lifestyle changes ...

We recently compiled a list of the 12 High Flying AI Stocks This Week. In this article, we are going to take a look at where ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential.

A colorectal surgeon named Dr Cedrek McFadden has shared the top five reasons why people may be at risk of getting colorectal ...

Morgan Stanley lowered the firm’s price target on Ball Corp. (BALL) to $70 from $75 and keeps an Overweight rating on the shares. Ball shares ...

ETH Zurich researchers collected cells from overweight individuals to identify biological markers that raise the risk of metabolic diseases.

AbbVie (NYSE:ABBV – Get Free Report) had its target price raised by equities research analysts at Wells Fargo & Company from $195.00 to $210.00 in a note issued to investors on Monday,Benzinga reports ...

Managers see mixed opportunities in emerging markets and a broadening opportunity set for small caps across global markets.

Both high-protein and low-carb diets are effective for weight loss. Consuming more protein may be the most important factor ...